Lombard Odier Asset Management »

Halozyme Therapeutics shares owned by Lombard Odier Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lombard Odier Asset Management from 13F filings

Historical chart of Lombard Odier Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Lombard Odier Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Lombard Odier Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1M 175k 40.68
2023-03-31 $2.8M 74k 38.19
2022-12-31 $18M 314k 56.90
2022-09-30 $16M 397k 39.54
2022-06-30 $19M 421k 44.00
2022-03-31 $25M 614k 39.88
2021-06-30 $14M 300k 45.41
2021-03-31 $19M 450k 41.69
2020-12-31 $20M 470k 42.71
2020-09-30 $15M 550k 26.28
2020-06-30 $17M 630k 26.81
2020-03-31 $16M 900k 17.99
2019-12-31 $16M 900k 17.73
2019-09-30 $4.7M 300k 15.51
2019-06-30 $9.4M 550k 17.18
2018-09-30 $9.1M 500k 18.17
2017-12-31 $6.6M 325k 20.26
2017-09-30 $3.5M 200k 17.37
2017-06-30 $1.8M 139k 12.82
2017-03-31 $3.9M 300k 12.96
2016-12-31 $3.6M 360k 9.88
2016-09-30 $2.4M 200k 11.94
2015-12-31 $8.3M 480k 17.33
2015-06-30 $4.9M 218k 22.58
2014-06-30 $4.2M 426k 9.88